Literature DB >> 24429354

Hereditary gynecologic cancers.

David Mutch, Lynette Denny, Michael Quinn.   

Abstract

Entities:  

Keywords:  BRCA1 and BRCA2; Breast cancer; Genetic risk assessment; Germline mutations; Intensified early cancer detection; Ovarian cancer; Prophylactic surgery; Screening and prevention

Mesh：

Year:  2013        PMID： 24429354     DOI： 10.1016/j.ijgo.2013.12.001

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN： 0020-7292            Impact factor:   3.561


× No keyword cloud information.
  5 in total

1.  Low 25-OH vitamin D levels at time of diagnosis and recurrence of ovarian cancer.

Authors:  Teresa Granato; Lucia Manganaro; Luca Petri; Maria Grazia Porpora; Valentina Viggiani; Antonio Angeloni; Emanuela Anastasi
Journal:  Tumour Biol       Date:  2015-09-09

2.  Two sisters with Mayer-Rokitansky-Küster-Hauser syndrome and serous adenocarcinoma of the ovary.

Authors:  Sarah P Huepenbecker; Laura Divine; Christina S Chu; David G Mutch
Journal:  Gynecol Oncol Rep       Date:  2017-09-07

Review 3.  Hereditary Gynecologic Cancer Syndromes - A Narrative Review.

Authors:  Stoyan Kostov; Rafał Watrowski; Yavor Kornovski; Deyan Dzhenkov; Stanislav Slavchev; Yonka Ivanova; Angel Yordanov
Journal:  Onco Targets Ther       Date:  2022-04-08       Impact factor: 4.147

4.  Investigation of estrogen receptor (ESR1) for breast cancer from traditional Chinese medicine.

Authors:  Tzu-Chieh Hung; Wen-Yuan Lee; Kuen-Bao Chen; Yueh-Chiu Chan; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-26       Impact factor: 3.411

5.  Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol.

Authors:  Fahima Dossa; Maria C Cusimano; Rinku Sutradhar; Kelly Metcalfe; Tari Little; Jordan Lerner-Ellis; Andrea Eisen; Wendy S Meschino; Nancy N Baxter
Journal:  BMJ Open       Date:  2018-09-04       Impact factor: 2.692
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.